Acute Lymphoblastic Leukaemia Clinical Trials

11 recruiting

Acute Lymphoblastic Leukaemia Trials at a Glance

12 actively recruiting trials for acute lymphoblastic leukaemia are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Phase 2 with 7 trials, with the heaviest enrollment activity in Halle, London, and Bologna. Lead sponsors running acute lymphoblastic leukaemia studies include AstraZeneca, Hospital Universitario Dr. Jose E. Gonzalez, and Arkansas Children's Hospital Research Institute.

Browse acute lymphoblastic leukaemia trials by phase

Treatments under study

About Acute Lymphoblastic Leukaemia Clinical Trials

Looking for clinical trials for Acute Lymphoblastic Leukaemia? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acute Lymphoblastic Leukaemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acute Lymphoblastic Leukaemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 1Phase 2

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Acute Lymphoblastic LeukaemiaAcute Myeloid Leukaemia
AstraZeneca84 enrolled30 locationsNCT07155226
Recruiting

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

B-cell Acute Lymphoblastic LeukemiaB-Cell Lymphoblastic LeukemiaB-cell Acute Lymphoblastic Leukemia (B-ALL)+4 more
Arkansas Children's Hospital Research Institute300 enrolled2 locationsNCT07422337
Recruiting
Not Applicable

Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy

Acute Lymphoblastic Leukaemias (ALL)Long Term Follow-Up
University of Erlangen-Nürnberg Medical School30 enrolled1 locationNCT07313878
Recruiting

Blinatumomab Consolidation in Real World

B-Cell Acute Lymphoblastic Leukaemia
Medical College of Wisconsin200 enrolled1 locationNCT07117136
Recruiting
Phase 2

Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients

Philadelphia Chromosome Negative ALLAcute Lymphobkastic LeukemiaAcute Lymphoblastic Leukaemia Recurrent
Hospital Universitario Dr. Jose E. Gonzalez12 enrolled1 locationNCT07039877
Recruiting
Phase 2Phase 3

Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL

Relapsed B Acute Lymphoblastic LeukaemiaRefractory B Acute Lymphoblastic Leukaemia
National University of Malaysia10 enrolled1 locationNCT03937544
Recruiting
Phase 2

Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial

Acute Myeloid LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome+3 more
Imperial College London50 enrolled8 locationsNCT06355583
Recruiting
Phase 2Phase 3

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia
St. Anna Kinderkrebsforschung1,800 enrolled119 locationsNCT01949129
Recruiting
Phase 2

A multi-centre phase II, Australian and New Zealand, exploratory study of amendments to conditioning regimens in haplo-identical stem cell transplantation

transformed AML/ MDSMyeloproliferative DisordersHodgkin's Disease+4 more
St Vincent's Hospital, Sydney127 enrolled10 locationsACTRN12622001232729
Recruiting
Phase 1

Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Bone Marrow Transplant

Acute Lymphoblastic LeukaemiaNon-Hodgkins LymphomaChronic Lymphocytic Leukaemia
Western Sydney Local Health District, Westmead Hospital20 enrolled3 locationsACTRN12617001579381
Recruiting
Phase 2

A phase II study of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide as Graft versus Host Disease (GVHD) prophylaxis

Non Hodgkin's Disease in remissionAcute Myeloid Leukaemia in first or second complete remissionacute Lymphoblastic Leukaemia in first or second complete remission+7 more
St Vincent's Hospital Sydney70 enrolled6 locationsACTRN12617000151336
Recruiting

Bright light therapy to improve sleep and quality of life in children with acute lymphoblastic leukaemia

Quality of LifeFatigueAcute Lymphoblastic Leukaemia+1 more
Lisa Walter80 enrolled2 locationsACTRN12616000187448